Ameliorating Metabolic Profiles After Kidney Transplantation: A Protocol for an Open-Label, Prospective, Randomized, 3-Arm, Controlled Trial

Frontiers in Medicine

Xianding Wang¹  Ming Ma¹  Tao Lin¹  Yu Fan¹  Saifu Yin¹  Turun Song¹  Zhongli Huang¹ 

[1] Department of Urology, West China Hospital, Sichuan University, Chengdu, China;Institute of Urology, West China Hospital, Sichuan University, Chengdu, China;Organ Transplant Center, West China Hospital, Sichuan University, Chengdu, China;

关键词: metformin;    empagliflozin;    kidney transplantation;    metabolic disorders;    clinical trial;   

DOI  :  10.3389/fmed.2021.800872

来源: Frontiers

【 授权许可】

CC BY